Calumet Current Deferred Revenue from 2010 to 2024
| CLMT Stock | USD 21.38 0.45 2.06% |
Current Deferred Revenue | First Reported 2005-09-30 | Previous Quarter 585.2 M | Current Value 450.4 M | Quarterly Volatility 108.3 M |
Check Calumet Specialty financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Calumet Specialty's main balance sheet or income statement drivers, such as Depreciation And Amortization of 89.3 M, Interest Expense of 232.8 M or Selling General Administrative of 154 M, as well as many indicators such as Price To Sales Ratio of 0.26, Dividend Yield of 0.096 or Days Sales Outstanding of 26.35. Calumet financial statements analysis is a perfect complement when working with Calumet Specialty Valuation or Volatility modules.
Calumet | Current Deferred Revenue |
Latest Calumet Specialty's Current Deferred Revenue Growth Pattern
Below is the plot of the Current Deferred Revenue of Calumet Specialty Products over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. Calumet Specialty's Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Calumet Specialty's overall financial position and show how it may be relating to other accounts over time.
| Current Deferred Revenue | 10 Years Trend |
|
Current Deferred Revenue |
| Timeline |
Calumet Current Deferred Revenue Regression Statistics
| Arithmetic Mean | 113,271,267 | |
| Geometric Mean | 77,767,905 | |
| Coefficient Of Variation | 79.25 | |
| Mean Deviation | 69,237,724 | |
| Median | 81,900,000 | |
| Standard Deviation | 89,761,998 | |
| Sample Variance | 8057.2T | |
| Range | 328.4M | |
| R-Value | 0.71 | |
| Mean Square Error | 4260.2T | |
| R-Squared | 0.51 | |
| Significance | 0 | |
| Slope | 14,320,111 | |
| Total Sum of Squares | 112801T |
Calumet Current Deferred Revenue History
About Calumet Specialty Financial Statements
Calumet Specialty shareholders use historical fundamental indicators, such as Current Deferred Revenue, to determine how well the company is positioned to perform in the future. Although Calumet Specialty investors may analyze each financial statement separately, they are all interrelated. The changes in Calumet Specialty's assets and liabilities, for example, are also reflected in the revenues and expenses on on Calumet Specialty's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 219 M | 229.9 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Calumet Stock Analysis
When running Calumet Specialty's price analysis, check to measure Calumet Specialty's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Calumet Specialty is operating at the current time. Most of Calumet Specialty's value examination focuses on studying past and present price action to predict the probability of Calumet Specialty's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Calumet Specialty's price. Additionally, you may evaluate how the addition of Calumet Specialty to your portfolios can decrease your overall portfolio volatility.